NuVasive announced that it is restructuring to achieve strategic goals, including a scalable worldwide commercial organization, streamlined global operations and improved product development and commercialization capability. The company also made a number of appointments, including the promotion of Matt Link, president of US Commercial, to executive vice president of strategy, technology and corporate development.
NuVasive announces organizational restructuring, leadership changes
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.